Rock Springs Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Rock Springs Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-119,188	Closed	-$13.8M	–	170
2020 Q4	$13.8M	Hold	119,188	–	–	0.29%	98
2020 Q3	$11.6M	Sell	119,188 -855	-0.7%	-$98.4K	0.29%	90
2020 Q2	$14.7M	Buy	120,043 +90,043	+300%	+$10.2M	0.4%	84
2020 Q1	$2.63M	Buy	+30,000	New	+$3.18M	0.11%	119
2019 Q4	–	Sell	-95,000	Closed	-$10.9M	–	144
2019 Q3	$10.9M	Sell	95,000 -510,000	-84%	-$77.4M	0.44%	73
2019 Q2	$104M	Sell	605,000 -95,000	-14%	-$16.4M	3.77%	2
2019 Q1	$118M	Buy	700,000 +100,500	+17%	+$15M	4.55%	2
2018 Q4	$58.4M	Buy	599,500 +199,500	+50%	+$26.2M	2.76%	5
2018 Q3	$69.1M	Sell	400,000 -40,000	-9%	-$5.77M	2.5%	8
2018 Q2	$61.4M	Buy	440,000 +80,000	+22%	+$11.4M	2.36%	5
2018 Q1	$40.6M	Buy	360,000 +6,000	+2%	+$754K	1.73%	11
2017 Q4	$46.7M	Sell	354,000 -19,000	-5%	-$2.23M	2.12%	8
2017 Q3	$37.9M	Buy	373,000 +7,500	+2%	+$803K	1.75%	14
2017 Q2	$36.6M	Buy	365,500 +9,000	+3%	+$969K	1.85%	13
2017 Q1	$43.1M	Buy	356,500 +500	+0.1%	+$61.3K	2.49%	6
2016 Q4	$39.8M	Buy	356,000 +31,000	+10%	+$3.73M	2.66%	5
2016 Q3	$43.1M	Buy	325,000 +55,000	+20%	+$5.26M	2.7%	5
2016 Q2	$24.7M	Buy	270,000 +123,000	+84%	+$10.4M	1.83%	16
2016 Q1	$10.6M	Buy	147,000 +31,000	+27%	+$1.7M	0.89%	35
2015 Q4	$8.05M	Buy	116,000 +30,500	+36%	+$2.48M	0.61%	59
2015 Q3	$7.81M	Buy	85,500 +12,250	+17%	+$1.36M	0.63%	56
2015 Q2	$9M	Buy	73,250 +3,250	+5%	+$369K	0.66%	53
2015 Q1	$6.38M	Buy	70,000 +42,000	+150%	+$3.41M	0.6%	58
2014 Q4	$1.9M	Buy	+28,000	New	+$2.05M	0.22%	86
2014 Q2	–	Sell	-17,750	Closed	-$1.05M	–	92
2014 Q1	$1.05M	Buy	+17,750	New	+$1.06M	0.24%	72

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rock Springs Capital Management's GWPH Position: Q1 2021 in Review

Rock Springs Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 119,188 shares — an estimated $13.8M sold.

Rock Springs Capital Management first reported a position in GWPH in Q1 2014 and held it in 25 quarters. The position peaked at $118M in Q1 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Rock Springs Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Rock Springs Capital Management sold 119,188 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $13.8M.
Rock Springs Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 25 quarters.
Rock Springs Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $118M in Q1 2019.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Rock Springs Capital Management's 13F filing for Q1 2021, filed 17 May 2021.